In all three models, MCT treatment significantly extended progression-free survival (PFS) (Fig. 1b) and reduced tumor proliferation, as depicted by H-Score of Ki-67 staining (Supplementary Fig. 1b). The gene discussed is MKI67; the disease is neoplasm.